FAM225A and hepatocellular carcinoma: In addition, FAM225A knockdown caused an augment of miR-130a-5p expression, and miR-130a-5p inhibitor abrogated the enhanced sensitivity of HCC cells to sorafenib treatment caused by FAM225A deletion.